Stephanie Ailey is a highly accomplished industry veteran with over 20 years of experience in program management and healthcare. As the Vice President of Business Development at DM Clinical Research, she brings invaluable expertise to the national clinical trial site network. Her exceptional track record in building strategic relationships has been instrumental in driving the company’s success.
Stephanie’s passion for research is evident in her unique experience working at the study site that enrolled the first patient globally in a Phase 3 COVID-19 trial. Recognized for her leadership and contributions, she was honored with the 2025 Women Who Mean Business award by the Houston Business Journal.
With a strong commitment to diversity and a dedication to making a positive impact, Stephanie is poised to lead DM Clinical Research into new frontiers of growth and innovation.